A Rare Case of Lipoprotein Glomerulopathy in a White Man An Emerging Entity in Asia, Rare in the White Population

Department of Pathology, University of Illinois, 835 S Wood St, Chicago, IL 60612, USA.
Archives of pathology & laboratory medicine (Impact Factor: 2.84). 02/2010; 134(2):279-82. DOI: 10.1043/1543-2165-134.2.279
Source: PubMed


Lipoprotein glomerulopathy is a rare entity that predominantly affects the Asian population, mainly the Japanese and Chinese. Lipoprotein glomerulopathy is clinically characterized by proteinuria and progression to renal failure and is caused by glomerular lipoprotein thrombi formation in association with increased levels of serum apolipoprotein E. The disease has a male predominance and can affect virtually any age group. We describe the third reported case, to our knowledge, of lipoprotein glomerulopathy to affect a white patient.

2 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lipoprotein glomerulopathy is a rare disease diagnosed by unique histopathologic findings of glomerular capillary dilatation by lipoprotein thrombi. The disease is caused by mutations in apoE, the gene that encodes apolipoprotein E. To date, <80 cases have been reported in the medical literature, nearly all of which are from Japan or China. Only five cases from the United States have previously been reported, of which three patients were of European ancestry. Here, we present the fourth case of lipoprotein glomerulopathy in a European-American man. Whereas prior European-American patients with lipoprotein glomerulopathy were found to have the previously reported apoE Kyoto genotype, the patient presented here was found to have a novel mutation that we have named apoE Las Vegas.
    No preview · Article · Oct 2010 · Nephrology Dialysis Transplantation
  • [Show abstract] [Hide abstract]
    ABSTRACT: Apolipoprotein E (apoE) is an important plasma protein in cholesterol homeostasis and plays a key role in the progression of glomerulosclerosis (GS). We conducted this investigation to explore whether all-trans retinoic acid (ATRA) could regulate the apoE expression in the pathological process of GS. 120 Wistar rats were divided into three groups at random: sham operation group (SHO), glomerulosclerosis model group without treatment (GS), GS model group treated with ATRA (GA); n=40, respectively. The disease of GS in rat was established by uninephrectomy and adriamycin (5mg/kg) injection. At the end of 9 and 13 weeks, 20 rats in each group were killed and the relevant samples were collected. 24-hour urine total protein (24UTP), 24-hour urine excretion for albumin (24Ualb), serum total protein (TP) and serum albumin (Alb), blood urea nitrogen (BUN), serum creatinine (Scr), total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), serum and urine apoE and glomerulosclerosis index (GSI) were measured. The protein expressions of collagen IV (Col-IV), fibronectin (FN) and apoE in glomeruli were determined by immunohistochemistry. Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) was used to detect the expression of apoE mRNA in kidney. TP and Alb in GA group in 9/13-week were increased than those of GS group, however, the differences were not statistically significant. Compared with group GS at 9/13 weeks, values of 24UTP, 24Ualb, BUN, Scr, TC, TG, HDL, LDL, serum and urine apoE, and GSI in GA group that were significantly reduced, and protein expressions of Col-IV, FN and apoE in glomeruli and expression of apoE mRNA in renal tissue were significantly down-regulated by ATRA (P<0.01). In conclusion, ATRA can regulate the expression of apoE, reduce the accumulation of extracellular matrix (ECM) and step down the progression of GS.
    No preview · Article · Mar 2011 · Experimental and Molecular Pathology
  • [Show abstract] [Hide abstract]
    ABSTRACT: It is well established that apolipoproteins play a crucial role in serum lipids transport and metabolism. Particularly, the apolipoprotein E (apoE) is mainly involved in the transport of very-low density lipoproteins and intermediary density lipoproteins by the liver, but new insights revealed a wide range of functions performed by apoE. This lipoprotein is related to the modulation of inflammatory process and regulates the expression of multiple genes in various diseases. Besides, apoE isoforms are involved in progression of cardiovascular and renal diseases. Here we present a review about the achievements in both experimental and clinical studies that contribute to understanding the role of apoE in both physiological and pathological situations. We focus in the participation of apoE as a key modulatory factor to the development of atherosclerosis, diabetes and kidney diseases and the contributions of available animal models to clarify the mechanisms involved in these pathologies in humans.
    No preview · Article · Oct 2012
Show more